(Q35021208)

5 August 2017

title

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours (English)

1 reference

5 August 2017

main subject

phase I clinical trial

0 references

author

Adrian Harris

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Philip Hogg

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Geoffrey J Parker

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Caroline Dive

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gordon C. Jayson

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Laura Horsley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jeff Cummings

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mark Middleton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Tim Ward

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Alison Backen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Andrew Clamp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Martin Dawson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Hayley Farmer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nita Fisher

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gavin Halbert

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sarah Halford

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jurjees Hasan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gireesh Kumaran

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ross Little

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paula Potter

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mark Saunders

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Caleb Roberts

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Danielle Shaw

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nigel Smith

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jon Smythe

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Andrew Taylor

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Helen Turner

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yvonne Watson

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Cancer Research UK Drug Development Office Phase I clinical trial

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

20 October 2013

1 reference

Cancer Chemotherapy and Pharmacology

5 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1343-1352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Optimisation of circulating biomarkers of cell death for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Arsenic toxicity and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Mitochondria as targets in angiogenesis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Mitochondrial metabolism inhibitors for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

History of the development of arsenic derivatives in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2320-9

10.1007/S00280-013-2320-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json

release_kzg2immjkfb25bvnf3yaghymn4

2 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kzg2immjkfb25bvnf3yaghymn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24141375%20AND%20SRC:MED&resulttype=core&format=json